Published in J Child Adolesc Psychopharmacol on October 01, 2009
Advances in understanding and treating ADHD. BMC Med (2011) 1.21
An update on the pharmacotherapy of attention-deficit/hyperactivity disorder in adults. Expert Rev Neurother (2011) 1.15
Atomoxetine for the treatment of attention-deficit/hyperactivity disorder in children and adolescents: a review. Neuropsychiatr Dis Treat (2009) 1.06
An open study of adjunct OROS-methylphenidate in children who are atomoxetine partial responders: II. Tolerability and pharmacokinetics. J Child Adolesc Psychopharmacol (2009) 0.89
Performance on a strategy set shifting task during adolescence in a genetic model of attention deficit/hyperactivity disorder: methylphenidate vs. atomoxetine treatments. Behav Brain Res (2013) 0.88
A systematic review of combination therapy with stimulants and atomoxetine for attention-deficit/hyperactivity disorder, including patient characteristics, treatment strategies, effectiveness, and tolerability. J Child Adolesc Psychopharmacol (2013) 0.82
Acupuncture for attention deficit hyperactivity disorder (ADHD): study protocol for a randomised controlled trial. Trials (2011) 0.80
Adolescent d-amphetamine treatment in a rodent model of ADHD: Pro-cognitive effects in adolescence without an impact on cocaine cue reactivity in adulthood. Behav Brain Res (2015) 0.78
Pharmacological treatment of attention deficit hyperactivity disorder in children and adolescents: clinical strategies. J Cent Nerv Syst Dis (2012) 0.77
Telepsychiatrists' Medication Treatment Strategies in the Children's Attention-Deficit/Hyperactivity Disorder Telemental Health Treatment Study. J Child Adolesc Psychopharmacol (2015) 0.77
Efficacy and safety of atomoxetine in the treatment of children and adolescents with attention deficit hyperactivity disorder. Clin Med Insights Pediatr (2012) 0.77
A critical appraisal of atomoxetine in the management of ADHD. Ther Clin Risk Manag (2015) 0.76
Atomoxetine and stimulant medications in children and adolescents with persistent symptoms of attention deficit hyperactivity disorder despite monotherapy. Can Pharm J (Ott) (2012) 0.75
Executive functions and developmental psychopathology. J Child Psychol Psychiatry (1996) 5.90
Historical development and present status of the schedule for affective disorders and schizophrenia for school-age children (K-SADS). J Am Acad Child Adolesc Psychiatry (2000) 5.60
The Texas Children's Medication Algorithm Project: revision of the algorithm for pharmacotherapy of attention-deficit/hyperactivity disorder. J Am Acad Child Adolesc Psychiatry (2006) 4.58
Practice parameter for the use of stimulant medications in the treatment of children, adolescents, and adults. J Am Acad Child Adolesc Psychiatry (2002) 4.57
Once-daily atomoxetine treatment for children and adolescents with attention deficit hyperactivity disorder: a randomized, placebo-controlled study. Am J Psychiatry (2002) 3.89
Clinical relevance of the primary findings of the MTA: success rates based on severity of ADHD and ODD symptoms at the end of treatment. J Am Acad Child Adolesc Psychiatry (2001) 3.87
Treatment of ADHD in children with tics: a randomized controlled trial. Neurology (2002) 3.63
Developmental change in attention-deficit hyperactivity disorder in boys: a four-year longitudinal study. J Abnorm Child Psychol (1995) 2.55
Atomoxetine in the treatment of children and adolescents with attention-deficit/hyperactivity disorder: a randomized, placebo-controlled, dose-response study. Pediatrics (2001) 2.48
Meta-analysis of the efficacy of methylphenidate for treating adult attention-deficit/hyperactivity disorder. J Clin Psychopharmacol (2004) 2.36
Impact of executive function deficits and attention-deficit/hyperactivity disorder (ADHD) on academic outcomes in children. J Consult Clin Psychol (2004) 2.30
Attention deficit/hyperactivity disorder across the lifespan. Annu Rev Med (2002) 2.19
Combined pharmacotherapy: an emerging trend in pediatric psychopharmacology. J Am Acad Child Adolesc Psychiatry (1995) 1.98
Validity of the behavior rating inventory of executive function in children with ADHD and/or Tourette syndrome. Arch Clin Neuropsychol (2002) 1.69
The adolescent outcome of hyperactive children diagnosed by research criteria: II. Academic, attentional, and neuropsychological status. J Consult Clin Psychol (1990) 1.63
Confirmatory factor analysis of the Behavior Rating Inventory of Executive Function (BRIEF) in a clinical sample. Child Neuropsychol (2002) 1.58
Attention deficit disorder and methylphenidate: normalization rates, clinical effectiveness, and response prediction in 76 children. J Am Acad Child Adolesc Psychiatry (1994) 1.51
The stimulants revisited. Child Adolesc Psychiatr Clin N Am (2000) 1.48
Deficient inhibitory control in attention deficit hyperactivity disorder. J Abnorm Child Psychol (1995) 1.44
Effects of methylphenidate on the catecholaminergic system in attention-deficit/hyperactivity disorder. J Clin Psychopharmacol (2008) 1.44
Frontal lobe functions in attention deficit disorder with and without hyperactivity: a review and research report. J Abnorm Child Psychol (1992) 1.36
The relationship between parental report on the BRIEF and performance-based measures of executive function in children with moderate to severe traumatic brain injury. Child Neuropsychol (2002) 1.36
Toward defining a neuropsychology of attention deficit-hyperactivity disorder: performance of children and adolescents from a large clinically referred sample. J Consult Clin Psychol (1997) 1.35
Clonidine for attention-deficit/hyperactivity disorder: I. Efficacy and tolerability outcomes. J Am Acad Child Adolesc Psychiatry (2008) 1.27
A randomized controlled trial of clonidine added to psychostimulant medication for hyperactive and aggressive children. J Am Acad Child Adolesc Psychiatry (2003) 1.16
Mechanism of action of agents used in attention-deficit/hyperactivity disorder. J Clin Psychiatry (2006) 1.13
Atomoxetine and stimulants in combination for treatment of attention deficit hyperactivity disorder: four case reports. J Child Adolesc Psychopharmacol (2004) 1.10
Combination pharmacotherapy for adult ADHD. Curr Psychiatry Rep (2006) 1.04
Side effects of methylphenidate and desipramine alone and in combination in children. J Am Acad Child Adolesc Psychiatry (1993) 1.03
A pilot study for augmenting atomoxetine with methylphenidate: safety of concomitant therapy in children with attention-deficit/hyperactivity disorder. Child Adolesc Psychiatry Ment Health (2007) 0.98
Normalized functioning in youths with persistent attention-deficit/hyperactivity disorder. J Pediatr (1998) 0.92
An open study of adjunct OROS-methylphenidate in children who are atomoxetine partial responders: II. Tolerability and pharmacokinetics. J Child Adolesc Psychopharmacol (2009) 0.89
Misuse and diversion of stimulants prescribed for ADHD: a systematic review of the literature. J Am Acad Child Adolesc Psychiatry (2008) 3.52
A randomized, placebo-controlled trial of OROS methylphenidate in adults with attention-deficit/hyperactivity disorder. Biol Psychiatry (2005) 1.87
Does ADHD predict substance-use disorders? A 10-year follow-up study of young adults with ADHD. J Am Acad Child Adolesc Psychiatry (2011) 1.26
Effect of prior stimulant treatment for attention-deficit/hyperactivity disorder on subsequent risk for cigarette smoking and alcohol and drug use disorders in adolescents. Arch Pediatr Adolesc Med (2008) 1.24
Cigarette smoking associated with attention deficit hyperactivity disorder. J Pediatr (2008) 1.19
Presenting ADHD symptoms, subtypes, and comorbid disorders in clinically referred adults with ADHD. J Clin Psychiatry (2009) 1.18
Open-label, 8-week trial of olanzapine and risperidone for the treatment of bipolar disorder in preschool-age children. Biol Psychiatry (2005) 1.07
Differences in brain chemistry in children and adolescents with attention deficit hyperactivity disorder with and without comorbid bipolar disorder: a proton magnetic resonance spectroscopy study. Am J Psychiatry (2006) 1.05
A prospective open-label trial of lamotrigine monotherapy in children and adolescents with bipolar disorder. CNS Neurosci Ther (2010) 0.98
An open-label trial of OROS methylphenidate in adults with late-onset ADHD. CNS Spectr (2006) 0.95
A randomized, 3-phase, 34-week, double-blind, long-term efficacy study of osmotic-release oral system-methylphenidate in adults with attention-deficit/hyperactivity disorder. J Clin Psychopharmacol (2010) 0.95
Is oppositional defiant disorder a meaningful diagnosis in adults? Results from a large sample of adults with ADHD. J Nerv Ment Dis (2007) 0.94
The effects of lisdexamfetamine dimesylate on the driving performance of young adults with ADHD: a randomized, double-blind, placebo-controlled study using a validated driving simulator paradigm. J Psychiatr Res (2012) 0.94
Mania, glutamate/glutamine and risperidone in pediatric bipolar disorder: a proton magnetic resonance spectroscopy study of the anterior cingulate cortex. J Affect Disord (2006) 0.93
Preliminary examination of the reliability and concurrent validity of the attention-deficit/hyperactivity disorder self-report scale v1.1 symptom checklist to rate symptoms of attention-deficit/hyperactivity disorder in adolescents. J Child Adolesc Psychopharmacol (2012) 0.93
An open-label trial of aripiprazole monotherapy in children and adolescents with bipolar disorder. CNS Spectr (2007) 0.93
The familial association between cigarette smoking and ADHD: a study of clinically referred girls with and without ADHD, and their families. Nicotine Tob Res (2008) 0.93
A prospective open-label trial of extended-release carbamazepine monotherapy in children with bipolar disorder. J Child Adolesc Psychopharmacol (2010) 0.92
Guggul for hyperlipidemia: a review by the Natural Standard Research Collaboration. Complement Ther Med (2005) 0.90
Comparative acute efficacy and tolerability of OROS and immediate release formulations of methylphenidate in the treatment of adults with attention-deficit/hyperactivity disorder. BMC Psychiatry (2007) 0.90
An open study of adjunct OROS-methylphenidate in children who are atomoxetine partial responders: II. Tolerability and pharmacokinetics. J Child Adolesc Psychopharmacol (2009) 0.89
An open trial of bupropion for the treatment of adults with attention-deficit/hyperactivity disorder and bipolar disorder. Biol Psychiatry (2003) 0.88
Evidence-based systematic review of saw palmetto by the Natural Standard Research Collaboration. J Soc Integr Oncol (2006) 0.88
Fenugreek (Trigonella foenum-graecum L. Leguminosae): an evidence-based systematic review by the natural standard research collaboration. J Herb Pharmacother (2007) 0.88
Response to second generation antipsychotics in youth with comorbid bipolar disorder and autism spectrum disorder. CNS Neurosci Ther (2010) 0.87
Kava monograph: a clinical decision support tool. J Herb Pharmacother (2002) 0.87
Risperidone treatment for ADHD in children and adolescents with bipolar disorder. Neuropsychiatr Dis Treat (2008) 0.86
Cigarette smoking as a risk factor for other substance misuse: 10-year study of individuals with and without attention-deficit hyperactivity disorder. Br J Psychiatry (2012) 0.86
Thyme (Thymus vulgaris L.), thymol. J Herb Pharmacother (2004) 0.86
Does conduct disorder mediate the development of substance use disorders in adolescents with bipolar disorder? A case-control family study. J Clin Psychiatry (2009) 0.85
Safety review of kava (Piper methysticum) by the Natural Standard Research Collaboration. Expert Opin Drug Saf (2005) 0.85
A cardiopulmonary study of lisdexamfetamine in adults with attention-deficit/hyperactivity disorder. World J Biol Psychiatry (2012) 0.85
Flax and flaxseed oil (Linum usitatissimum): a review by the Natural Standard Research Collaboration. J Soc Integr Oncol (2007) 0.84
An evidence-based systematic review of Aloe vera by the natural standard research collaboration. J Herb Pharmacother (2007) 0.84
A controlled trial of the methylphenidate transdermal system on before-school functioning in children with attention-deficit/hyperactivity disorder. J Clin Psychiatry (2010) 0.83
Further evidence for robust familiality of pediatric bipolar I disorder: results from a very large controlled family study of pediatric bipolar I disorder and a meta-analysis. J Clin Psychiatry (2012) 0.83
Personal and familial correlates of bipolar (BP)-I disorder in children with a diagnosis of BP-I disorder with a positive child behavior checklist (CBCL)-severe dysregulation profile: a controlled study. J Affect Disord (2012) 0.82
Reasons for substance use among adolescents with bipolar disorder. Am J Addict (2010) 0.82
Essiac: systematic review by the natural standard research collaboration. J Soc Integr Oncol (2009) 0.82
A double-blind comparison of galantamine hydrogen bromide and placebo in adults with attention-deficit/hyperactivity disorder: a pilot study. J Clin Psychopharmacol (2006) 0.82
All better? How former anorexia nervosa patients define recovery and engaged in treatment. Eur Eat Disord Rev (2010) 0.81
A randomized, single-blind, substitution study of OROS methylphenidate (Concerta) in ADHD adults receiving immediate release methylphenidate. J Atten Disord (2010) 0.81
A prospective open-label trial of quetiapine monotherapy in preschool and school age children with bipolar spectrum disorder. J Affect Disord (2011) 0.80
An evidence-based systematic review of belladonna by the natural standard research collaboration. J Herb Pharmacother (2004) 0.80
Atomoxetine in the treatment of adults with subthreshold and/or late onset attention-deficit hyperactivity disorder-not otherwise specified (ADHD-NOS): a prospective open-label 6-week study. CNS Neurosci Ther (2010) 0.80
A magnetic resonance spectroscopy study of the anterior cingulate cortex in youth with emotional dysregulation. Isr J Psychiatry Relat Sci (2012) 0.79
Chaparral monograph:a clinical decision support tool. J Herb Pharmacother (2003) 0.78
A controlled study of a simulated workplace laboratory for adults with attention deficit hyperactivity disorder. Psychiatry Res (2012) 0.78
An evidence-based systematic review of elderberry and elderflower (Sambucus nigra) by the Natural Standard Research Collaboration. J Diet Suppl (2014) 0.78
Onset of efficacy of long-acting psychostimulants in pediatric attention-deficit/hyperactivity disorder. Postgrad Med (2008) 0.78
Maitake mushroom (Grifola frondosa): systematic review by the natural standard research collaboration. J Soc Integr Oncol (2009) 0.77
An Open Trial of Sustained Release Bupropion for Attention-Deficit/Hyperactivity Disorder in Adults with ADHD plus Substance Use Disorders. J ADHD Relat Disord (2010) 0.77
An evidence-based systematic review of gymnema (Gymnema sylvestre R. Br.) by the Natural Standard Research Collaboration. J Diet Suppl (2011) 0.77
The effects of lisdexamfetamine dimesylate on driving behaviors in young adults with ADHD assessed with the Manchester driving behavior questionnaire. J Adolesc Health (2012) 0.77
Wild yam (Dioscoreaceae). J Herb Pharmacother (2003) 0.77
Further evidence that pediatric-onset bipolar disorder comorbid with ADHD represents a distinct subtype: results from a large controlled family study. J Psychiatr Res (2012) 0.77
Linezolid: MAOI activity and potential drug interactions. Psychosomatics (2002) 0.76
Examining the nature of the association between attention-deficit hyperactivity disorder and nicotine dependence: a familial risk analysis. Can J Psychiatry (2013) 0.76
An evidence-based systematic review of vitamin A by the natural standard research collaboration. J Diet Suppl (2012) 0.75
Marshmallow (Althaea officinalis L.) monograph. J Herb Pharmacother (2003) 0.75